BioAura LabsCapsules
CAPSULES BIOAURA LABS
GHK-Cu
Capsules
Copper-peptide research, with formulation in view.
GHK-Cu is a copper-associated tripeptide complex investigated in biochemical and cell-based research. This BioAura listing identifies a 2 mg capsule presentation in a 60-capsule package.
For laboratory research use only.
Not for human or veterinary use.
2 mg · 60 capsules · Capsules
SELECT YOUR PRESENTATION Catalog preview
TECHNICAL OVERVIEW
Copper-peptide research, with formulation in view.
The reference complex combines the glycyl-L-histidyl-L-lysine peptide with copper. Studies may examine complex formation, stability, and cell-associated responses under controlled experimental conditions. Those questions depend on the chemical form and analytical identity of the supplied material.
This capsule listing is separate from BioAura’s GHK-Cu vials and nasal-format products. Excipients, extraction efficiency, and finished-product content must be evaluated independently. The catalog amount does not establish copper content, peptide content, or a confirmed per-capsule quantity.
RESEARCH CONTEXT
Finished-formulation extraction and assay
Comparison of analytical results with the declared quantity
Specifications
- Catalog identity
- GHK-Cu
- Research classification
- Copper-peptide complex · Capsule format
- Available presentations
- 2 mg · 60 capsules · Capsules
- Intended use
- For laboratory research use only. Not for human or veterinary use. Not for consumption or administration.
- Quantity interpretation
- Listed amounts identify catalog presentations, not doses. Confirm the content basis in the supplier specification.
- Identity and formulation
- Complex identity, copper/peptide content basis, per-capsule or package quantity, excipients, and finished-product assay.
- Lot-specific analytical results
- Pending. No purity, potency, sterility, endotoxin, or third-party testing claim is verified for this preview.
- Storage and stability
- Pending supplier instructions. No storage temperature, shelf life, or opened-container period is assigned.
Documentation & material status
Lot-specific records have not been supplied for this preview. Product imagery and general research literature do not establish the properties of a BioAura lot.
SPECTechnical specificationPending supplier verification
Complex identity, copper/peptide content basis, per-capsule or package quantity, excipients, and finished-product assay.
COACertificate of analysisLot-matched COA pending
Review the matching lot identifier, analytical methods, acceptance criteria, measured results, units, and issuing laboratory. A purity percentage alone does not establish content, identity, or suitability.
SDSSafety & handling recordsSupplier documentation pending
Obtain the relevant safety data, handling precautions, storage conditions, stability information, and disposal requirements before laboratory work.
PRODUCT QUESTIONS
Frequently Asked Questions
Is this interchangeable with the GHK-Cu vial?
No equivalence has been established. Format, excipients, quantity basis, and analytical recovery require separate documentation.
What does the listed presentation tell me?
2 mg · 60 capsules · Capsules. These are supplied catalog details. They do not specify an experimental concentration, dose, preparation procedure, or administration instruction.
Is this intended for human or veterinary use?
For laboratory research use only. Not for human or veterinary use. Not for consumption or administration. This page provides no treatment, dosing, reconstitution, or administration guidance.
Can I purchase through this preview?
No. Prices and shopping-bag interactions demonstrate the proposed store experience. Final prices, availability, shipping, and payment processing have not been activated.
CONTINUE EXPLORING